| 2025 | Model-informed development of bacteriophage therapy: bridging in vitro and in vivo efficacy against multidrug-resistant Pseudomonas aeruginosa
| MSYSTEMS |
| 2025 | Evaluating current status of network pharmacology for herbal medicine focusing on identifying mechanisms and therapeutic effects
| JOURNAL OF ADVANCED RESEARCH |
| 2025 | Application of population pharmacokinetic modeling of SVG-101 to evaluate proper dose selection | TRANSLATIONAL AND CLINICAL PHARMACOLOGY |
| 2025 | Bioequivalence of a Donepezil/Memantine 10/20 mg Fixed-Dose Combination Versus Single-Component Tablets in Healthy Korean Males | CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT |
| 2025 | Population Pharmacokinetic-Pharmacodynamic Modeling of Granulocyte Colony-Stimulating Factor to Optimize Dosing and Timing for CD34<SUP>+</SUP> Cell Harvesting
| Clinical and Translational Science |
| 2024 | Pharmacokinetics, pharmacodynamics, and safety of izuforant, an H4R inhibitor, in healthy subjects: A phase I single and multiple ascending dose study | CTS-CLINICAL AND TRANSLATIONAL SCIENCE |
| 2024 | Prediction of herb-drug interaction between hyperforin and sedative hypnotics (zolpidem, alprazolam, and midazolam) using physiologically-based pharmacokinetic modeling | MOLECULAR & CELLULAR TOXICOLOGY |
| 2024 | The Association between Serum Lipid Levels and Tinnitus Prevalence and Severity in Korean Elderly: A Nationwide Population-Based Cross-Sectional Study | Yonsei Medical Journal |
| 2024 | Pharmacokinetic Modeling of Bepotastine for Determination of Optimal Dosage Regimen in Pediatric Patients with Allergic Rhinitis or Urticaria | PHARMACEUTICS |
| 2024 | Assessment of Pharmacokinetic Effects of Herbal Medicines on Escitalopram | THERAPEUTICS AND CLINICAL RISK MANAGEMENT |
| 2024 | Antioxidant Efficacy of Hwangryunhaedok-tang through Nrf2 and AMPK Signaling Pathway against Neurological Disorders In Vivo and In Vitro | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
| 2024 | Population pharmacokinetic-pharmacodynamic modeling of clopidogrel for dose regimen optimization based on CYP2C19 phenotypes: A proof of concept study | CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY |
| 2023 | The efficacy and safety of low-molecular-weight collagen peptides for joint pain in patients with osteoarthritis: A randomized, double-blind, placebo-controlled study | Journal of Functional Foods |
| 2023 | Pharmacokinetic and pharmacodynamic drug-drug interactions between evogliptin and empagliflozin or dapagliflozin in healthy male volunteers | CTS-CLINICAL AND TRANSLATIONAL SCIENCE |
| 2023 | Pharmacokinetic and pharmacodynamic interaction of DWP16001, a sodium-glucose cotransporter-2 inhibitor, with phentermine in healthy subjects | Expert Opinion on Drug Metabolism and Toxicology |
| 2023 | The effects of long-term cumulative HbA1c exposure on the development and onset time of dementia in the patients with type 2 diabetes mellitus: Hospital based retrospective study (2005-2021) | DIABETES RESEARCH AND CLINICAL PRACTICE |
| 2023 | Evaluation of pharmacokinetic interactions between lobeglitazone, empagliflozin, and metformin in healthy subjects | Translational and Clinical Pharmacology |
| 2022 | Effect of Rifampicin on the Pharmacokinetics of Evogliptin in Healthy Volunteers | DRUG DESIGN DEVELOPMENT AND THERAPY |
| 2022 | Effects of Hepatic Impairment on the Pharmacokinetic Profile and Safety of Lobeglitazone | Clinical Pharmacology in Drug Development |
| 2021 | Comparison of the pharmacokinetics and pharmacodynamics of YH4808 in healthy subjects for defining an appropriate dosing regimen | TRANSLATIONAL AND CLINICAL PHARMACOLOGY |
| 2021 | Association between Daily Sunlight Exposure and Fractures in Older Korean Adults with Osteoporosis: A Nationwide Population-Based Cross-Sectional Study | YONSEI MEDICAL JOURNAL |
| 2021 | Pharmacokinetics and safety of evogliptin in hepatically impaired patients | British Journal of Clinical Pharmacology |
| 2021 | Population Pharmacokinetics of Primaquine in the Korean Population | PHARMACEUTICS |
| 2021 | Association Between 10-Year Fracture Probability and Nonalcoholic Fatty Liver Disease With or Without Sarcopenia in Korean Men: A Nationwide Population-Based Cross-Sectional Study | FRONTIERS IN ENDOCRINOLOGY |
| 2020 | Pharmacodynamic evaluation of yh4808 for helicobacter pylori eradication in healthy subjects | Translational and Clinical Pharmacology |
| 2020 | Association between daily sunlight exposure duration and diabetic retinopathy in Korean adults with diabetes: A nationwide population-based cross-sectional study | PLOS ONE |
| 2020 | A Population Pharmacokinetic and Pharmacodynamic Model of CKD-519 | PHARMACEUTICS |
| 2020 | Evaluation of pharmacokinetic interactions between amoxicillin, clarithromycin, and the potassium-competitive acid blocker YH4808 in healthy subjects | Translational and Clinical Pharmacology |
| 2019 | The safety, pharmacodynamics, and pharmacokinetics of immediate-release formulation containing esomeprazole 20 mg/sodium bicarbonate 800 mg in healthy adult male
| Drug Design, Development and Therapy |
| 2019 | Effects of Gelidium elegans on Weight and Fat Mass Reduction and Obesity Biomarkers in Overweight or Obese Adults: A Randomized Double-Blinded Study
| Nutrients |
| 2018 | Comparison of biosimilar filgrastim with a reference product: Pharmacokinetics, pharmacodynamics, and safety profiles in healthy volunteers | Drug Design, Development and Therapy |
| 2018 | Coagulant Effect and Tolerability of Yeast-Produced Recombinant Batroxobin in Healthy Adult Subjects | CLINICAL DRUG INVESTIGATION |
| 2018 | A comparison of the pharmacokinetic and pharmacodynamic properties of nitroglycerin according to the composition of the administration set: A preliminary study
| MEDICINE |
| 2017 | Pharmacokinetic drug interaction between atorvastatin and ezetimibe in healthy Korean volunteers | Translational and Clinical Pharmacology |
| 2017 | Effects of clarithromycin on the pharmacokinetics of evogliptin in healthy volunteers | JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS |
| 2017 | Comparison of Pharmacokinetics and Safety of a Fixed-dose Combination of Rosuvastatin and Ezetimibe Versus Separate Tablets in Healthy Subjects | CLINICAL THERAPEUTICS |
| 2017 | Pharmacokinetic interactions between glimepiride and rosuvastatin in healthy Korean subjects: does the SLCO1B1 or CYP2C9 genetic polymorphism affect these drug interactions? Observations and introspection of the bioanalysis
| DRUG DESIGN DEVELOPMENT AND THERAPY |
| 2017 | Decreased potency of fimasartan in liver cirrhosis was quantified using mixed-effects analysis
| Translational and Clinical Pharmacology |
| 2016 | Effects of JOINS® on the pharmacokinetic profiles of aceclofenac in healthy Korean volunteers: an open-label, multiple-dose, one sequence, two-period study
| Translational and Clinical Pharmacology |
| 2016 | Pharmacokinetics, pharmacodynamics and safety of CKD-519, a CETP inhibitor, in healthy subjects
| DRUG DESIGN DEVELOPMENT AND THERAPY |
| 2015 | Pharmacokinetic Interaction Between Amlodipine and Lobeglitazone, a Novel Peroxisome Proliferator–activated Receptor-γ Agonist, in Healthy Subjects | CLINICAL THERAPEUTICS |
| 2014 | Verapamil decreases the glucose-lowering effect of metformin in healthy volunteers
| BRITISH JOURNAL OF CLINICAL PHARMACOLOGY |
| 2014 | Effect of Ketoconazole on Lobeglitazone Pharmacokinetics in Korean Volunteers | CLINICAL THERAPEUTICS |
| 2014 | First-in-human study with new recombinant agalsidase beta (ISU303) in healthy subjects | JOURNAL OF CLINICAL PHARMACOLOGY |
| 2013 | Functional characterization of MATE2-K genetic variants and their effects on metformin pharmacokinetics | PHARMACOGENETICS AND GENOMICS |
| 2013 | Influence of Hepatic Dysfunction on the Pharmacokinetics and Safety of Fimasartan | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY |
| 2013 | Impact of ABCC2, ABCG2 and SLCO1B1 polymorphisms on the pharmacokinetics of pitavastatin in humans
| DRUG METABOLISM AND PHARMACOKINETICS |
| 2012 | Influence of ABCC2, SLCO1B1, and ABCG2 Polymorphisms on the Pharmacokinetics of Olmesartan | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY |
| 2012 | Is abdominal obesity associated with the 2009 influenza A (H1N1) pandemic in Korean school-aged children? | INFLUENZA AND OTHER RESPIRATORY VIRUSES |
| 2010 | Extended-Spectrum β-Lactamase을 생성하는 Escherichia Coli 감염에 의한 패혈증 1예
| Korean Journal of Family Medicine (가정의학회지) |
http://orcid.org/0000-0002-2319-1108
(37101909400)
